Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Agios Pharma (DE:8AP)
FRANKFURT:8AP
Holding DE:8AP?
Track your performance easily
See the Price Targets and Ratings of:
8AP Analyst Ratings
Strong Buy
6 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
8AP Stock 12 Month Forecast
Average Price Target
€50.58
▼(-8.03% Downside)
| Highest Price Target€52.70 | Average Price Target€50.58 | Lowest Price Target€47.99 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
Reiterated
11/11/24
Scotiabank
Reiterated
11/01/24
Bank of America Securities
Assigned
11/01/24
RBC Capital
Assigned
10/31/24
TD Cowen
Reiterated
10/31/24
Piper Sandler
Assigned
10/23/24
Raymond James
Initiated
10/10/24
J.P. Morgan
€43.29
Hold
-21.29%
Downside
Initiated
06/13/24
Agios Pharmaceuticals reinstated with a Neutral at JPMorganAgios Pharmaceuticals reinstated with a Neutral at JPMorgan
Goldman Sachs
€31.05→€49.88
Hold
-9.32%
Downside
Reiterated
06/04/24
Agios Pharma (AGIO) PT Raised to $53 at Goldman SachsGoldman Sachs analyst Salveen Richter raised the price target on Agios Pharma (NASDAQ: AGIO) to $53.00 (from $33.00) while maintaining a Neutral rating.
Cantor Fitzgerald
―
Buy
―
Reiterated
05/28/24
Agios investors paying nothing for Pyrukynd, says Cantor FitzgeraldAgios investors paying nothing for Pyrukynd, says Cantor Fitzgerald
Best Analysts Covering Agios Pharma
Which Analyst Should I Follow If I Want to Buy DE:8AP and Sell After:
1 Month
xxx
Success Rate
7/10 ratings generated profit
Average Return
+6.71%
reiterated a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 70.00% of your transactions generating a profit, with an average return of +6.71% per trade.
3 Months
xxx
Success Rate
17/22 ratings generated profit
Average Return
+14.96%
assigned a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 77.27% of your transactions generating a profit, with an average return of +14.96% per trade.
1 Year
Success Rate
9/10 ratings generated profit
Average Return
+40.34%
assigned a buy rating 22 days ago
Copying Christopher Raymond's trades and holding each position for 1 Year would result in 90.00% of your transactions generating a profit, with an average return of +40.34% per trade.
2 Years
xxx
Success Rate
22/22 ratings generated profit
Average Return
+97.63%
assigned a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +97.63% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
8AP Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
1
0
0
0
0
Buy
14
12
10
16
13
Hold
3
2
1
3
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
14
11
19
17
Each month's total comprises the sum of three months' worth of ratings.
8AP Financial Forecast
8AP Stock Forecast FAQ
What is DE:8AP’s average 12-month price target, according to analysts?
Based on analyst ratings, Agios Pharma’s 12-month average price target is €50.58.
What is DE:8AP’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:8AP, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Agios Pharma a Buy, Sell or Hold?
Agios Pharma has a consensus rating of Strong Buy, which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.
What is Agios Pharma’s share price target?
The average share price target for Agios Pharma is €50.58. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €52.70 ,and the lowest forecast is €47.99. The average share price target represents -8.03% Decrease from the current price of €55.
The highest analyst share price target is €52.70 ,and the lowest forecast is €47.99. The average share price target represents -8.03% Decrease from the current price of €55.
What do analysts say about Agios Pharma?
Agios Pharma’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of Agios Pharma?
To buy shares of DE:8AP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.